Healthcare -
Biotechnology - NASDAQ - US
$ 7.26
1.11 %
$ 565 M
Market Cap
-3.09
P/E
KURA - COST OF REVENUE
Cost of Revenue KURA - Kura Oncology, Inc.
849 K
LAST VALUE
23.35%
2 YEAR CAGR
143.10%
5 YEAR CAGR
43.62%
10 YEAR CAGR